Correction: Long-term safety and clinical outcomes of olipudase alfa enzyme replacement therapy in pediatric patients with acid sphingomyelinase deficiency: two-year results (Orphanet Journal of Rare Diseases, (2022), 17, 1, (437), 10.1186/s13023-022-02587-0)

George A. Diaz; Roberto Giugliani; Nathalie Gufon; Simon A. Jones; Eugen Mengel; Maurizio Scarpa; Peter Witters; Abhimanyu Yarramaneni; Jing Li; Nicole M. Armstrong; Yong Kim; Catherine Ortemann-Renon; Monica Kumar

doi:10.1186/s13023-023-02647-z

Correction: Long-term safety and clinical outcomes of olipudase alfa enzyme replacement therapy in pediatric patients with acid sphingomyelinase deficiency: two-year results (Orphanet Journal of Rare Diseases, (2022), 17, 1, (437), 10.1186/s13023-022-02587-0)

George A. Diaz, Roberto Giugliani, Nathalie Gufon, Simon A. Jones, Eugen Mengel, Maurizio Scarpa, Peter Witters, Abhimanyu Yarramaneni, Jing Li, Nicole M. Armstrong, Yong Kim, Catherine Ortemann-Renon, Monica Kumar

Research output: Contribution to journal › Comment/debate

Abstract

Following publication of the original article [1], we have been notified that Fig. 1 was published incorrectly. Correct Fig. 1 should be as per below: (Figure presented.).

Original language	English
Article number	55
Journal	Orphanet Journal of Rare Diseases
Volume	18
Issue number	1
DOIs	https://doi.org/10.1186/s13023-023-02647-z
State	Published - Dec 2023

Access to Document

10.1186/s13023-023-02647-z

Fingerprint

Dive into the research topics of 'Correction: Long-term safety and clinical outcomes of olipudase alfa enzyme replacement therapy in pediatric patients with acid sphingomyelinase deficiency: two-year results (Orphanet Journal of Rare Diseases, (2022), 17, 1, (437), 10.1186/s13023-022-02587-0)'. Together they form a unique fingerprint.

Cite this

Diaz, G. A., Giugliani, R., Gufon, N., Jones, S. A., Mengel, E., Scarpa, M., Witters, P., Yarramaneni, A., Li, J., Armstrong, N. M., Kim, Y., Ortemann-Renon, C., & Kumar, M. (2023). Correction: Long-term safety and clinical outcomes of olipudase alfa enzyme replacement therapy in pediatric patients with acid sphingomyelinase deficiency: two-year results (Orphanet Journal of Rare Diseases, (2022), 17, 1, (437), 10.1186/s13023-022-02587-0). Orphanet Journal of Rare Diseases, 18(1), [55]. https://doi.org/10.1186/s13023-023-02647-z

Diaz, George A. ; Giugliani, Roberto ; Gufon, Nathalie et al. / Correction : Long-term safety and clinical outcomes of olipudase alfa enzyme replacement therapy in pediatric patients with acid sphingomyelinase deficiency: two-year results (Orphanet Journal of Rare Diseases, (2022), 17, 1, (437), 10.1186/s13023-022-02587-0). In: Orphanet Journal of Rare Diseases. 2023 ; Vol. 18, No. 1.

@article{1bef8a299ec24f4db611b8a353848bb7,

title = "Correction: Long-term safety and clinical outcomes of olipudase alfa enzyme replacement therapy in pediatric patients with acid sphingomyelinase deficiency: two-year results (Orphanet Journal of Rare Diseases, (2022), 17, 1, (437), 10.1186/s13023-022-02587-0)",

abstract = "Following publication of the original article [1], we have been notified that Fig. 1 was published incorrectly. Correct Fig. 1 should be as per below: (Figure presented.).",

author = "Diaz, {George A.} and Roberto Giugliani and Nathalie Gufon and Jones, {Simon A.} and Eugen Mengel and Maurizio Scarpa and Peter Witters and Abhimanyu Yarramaneni and Jing Li and Armstrong, {Nicole M.} and Yong Kim and Catherine Ortemann-Renon and Monica Kumar",

note = "Publisher Copyright: {\textcopyright} The Author(s) 2023.",

year = "2023",

month = dec,

doi = "10.1186/s13023-023-02647-z",

language = "English",

volume = "18",

journal = "Orphanet Journal of Rare Diseases",

issn = "1750-1172",

publisher = "BioMed Central Ltd.",

number = "1",

}

Diaz, GA, Giugliani, R, Gufon, N, Jones, SA, Mengel, E, Scarpa, M, Witters, P, Yarramaneni, A, Li, J, Armstrong, NM, Kim, Y, Ortemann-Renon, C & Kumar, M 2023, 'Correction: Long-term safety and clinical outcomes of olipudase alfa enzyme replacement therapy in pediatric patients with acid sphingomyelinase deficiency: two-year results (Orphanet Journal of Rare Diseases, (2022), 17, 1, (437), 10.1186/s13023-022-02587-0)', Orphanet Journal of Rare Diseases, vol. 18, no. 1, 55. https://doi.org/10.1186/s13023-023-02647-z

Correction: Long-term safety and clinical outcomes of olipudase alfa enzyme replacement therapy in pediatric patients with acid sphingomyelinase deficiency: two-year results (Orphanet Journal of Rare Diseases, (2022), 17, 1, (437), 10.1186/s13023-022-02587-0). / Diaz, George A.; Giugliani, Roberto; Gufon, Nathalie et al.
In: Orphanet Journal of Rare Diseases, Vol. 18, No. 1, 55, 12.2023.

Research output: Contribution to journal › Comment/debate

TY - JOUR

T1 - Correction

T2 - Long-term safety and clinical outcomes of olipudase alfa enzyme replacement therapy in pediatric patients with acid sphingomyelinase deficiency: two-year results (Orphanet Journal of Rare Diseases, (2022), 17, 1, (437), 10.1186/s13023-022-02587-0)

AU - Diaz, George A.

AU - Giugliani, Roberto

AU - Gufon, Nathalie

AU - Jones, Simon A.

AU - Mengel, Eugen

AU - Scarpa, Maurizio

AU - Witters, Peter

AU - Yarramaneni, Abhimanyu

AU - Li, Jing

AU - Armstrong, Nicole M.

AU - Kim, Yong

AU - Ortemann-Renon, Catherine

AU - Kumar, Monica

PY - 2023/12

Y1 - 2023/12

N2 - Following publication of the original article [1], we have been notified that Fig. 1 was published incorrectly. Correct Fig. 1 should be as per below: (Figure presented.).

AB - Following publication of the original article [1], we have been notified that Fig. 1 was published incorrectly. Correct Fig. 1 should be as per below: (Figure presented.).

UR - http://www.scopus.com/inward/record.url?scp=85150288048&partnerID=8YFLogxK

U2 - 10.1186/s13023-023-02647-z

DO - 10.1186/s13023-023-02647-z

M3 - Comment/debate

C2 - 36918897

AN - SCOPUS:85150288048

SN - 1750-1172

VL - 18

JO - Orphanet Journal of Rare Diseases

JF - Orphanet Journal of Rare Diseases

IS - 1

M1 - 55

ER -

Diaz GA, Giugliani R, Gufon N, Jones SA, Mengel E, Scarpa M et al. Correction: Long-term safety and clinical outcomes of olipudase alfa enzyme replacement therapy in pediatric patients with acid sphingomyelinase deficiency: two-year results (Orphanet Journal of Rare Diseases, (2022), 17, 1, (437), 10.1186/s13023-022-02587-0). Orphanet Journal of Rare Diseases. 2023 Dec;18(1):55. doi: 10.1186/s13023-023-02647-z